FNY Managed Accounts’s Pfizer PFE Stock Holding History

FNY Managed Accounts’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-379	Closed	-$1.74K	–	544
2015 Q2	$1.74K	Buy	+379	New	+$12.4K	﹤0.01%	409

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FNY Managed Accounts's PFE Position: Q3 2017 in Review

FNY Managed Accounts sold out of Pfizer (PFE) in Q3 2017, closing a stake of 479 shares — an estimated $15K sold.

FNY Managed Accounts first reported a position in PFE in Q1 2015 and held it in 3 quarters. The position peaked at $348K in Q1 2015. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

FNY Managed Accounts reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
FNY Managed Accounts sold 479 Pfizer shares in Q3 2017, an estimated $15K.
FNY Managed Accounts first reported a position in Pfizer in Q1 2015 and held it in 3 quarters.
FNY Managed Accounts's Pfizer position peaked at $348K in Q1 2015.
2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on FNY Managed Accounts's 13F filing for Q3 2017, filed 9 Nov 2017.